PERK-induced miR-211 inhibition of Bmal1 and Clock in tumor cells is another mechanism that has been recently demonstrated where this pathway inhibits circadian rhythm oscillations and ongoing protein synthesis, thereby promoting tumor progression [81]. Here, BMAL1 is linked to neoplasm.